Skip to main content
Log in

Role of insulin resistance in heart and skeletal muscle F-18 fluorodeoxyglucose uptake in patients with noninsulin-dependent diabetes mellitus

  • Original Articles
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

Background

Altered heart and skeletal glucose usage has been reported in patients with non-insulin-dependent diabetes mellitus (NIDDM). Although elevations in plasma free fatty acid (FFA) concentrations have been implicated in reduced myocardial 18fluorine-fluoro-2-deoxy-d-glucose uptake (MFU), the specific role of whole-body insulin resistance in MFU in patients with NIDDM compared with skeletal muscle metabolism remains controversial.

Purpose

MFU and skeletal muscle 18fluorine-fluoro-2-deoxy-d-glucose uptake (SMFU) were compared with positron emission tomography and the whole-body glucose disposal rate (GDR) during hyperinsulinemic euglycemic clamping in 26 normotensive asymptomatic patients with NIDDM who were not taking medication. These factors were also compared in 12 age-matched control subjects to increase the knowledge of the influence of whole-body insulin resistance on MFU. In addition, independent factors for both SMFU and MFU were investigated.

Results

GDR in control subjects (10.0±2.97 mg/min per kilogram) was significantly higher than in patients with NIDDM (4.05±2.37 mg/min per kilogram, P<.01). SMFU in patients with NIDDM (0.826 +-0.604 mg/min per 100g) was significantly lower than that in control subjects (1.86±1.06 mg/min per 100g, P<.01). MFU in patients with NIDDM (5.35±2.10 mg/min per 100 g) was also significantly lower than that of control subjects (7.05±1.66 mg/min per 100 g, P =.0182). SMFU significantly correlated with GDR (r=.727, P<.01) and FFA (r=-.52, P <.01) in patients with NIDDM. MFU also correlated with GDR (r=.778, P<.01) and FFA (r=-.72, P<.01) in patients with NIDDM. Multivariate stepwise regression analysis showed that GDR (F=36.8) was independently related to MFU (r=.85, P<.01) whereas FFA was not (F=1.763), where F is the value for statistical analysis of multivariate stepwise regression analysis.

Conclusion

Insulin resistance is the most essential factor for both heart and skeletal muscle FDG uptake in patients with NIDDM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Defronzo RA, Gunnarsson O, Bjorkman M, Olson J, Wahren.J. Effect of insulin on peripheral and splanchnic glucose metabolism in non-insulin dependent (type II) diabetes mellitus. J Clin Invest 1985;76:149–55.

    Article  PubMed  CAS  Google Scholar 

  2. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595–607.

    Article  PubMed  CAS  Google Scholar 

  3. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980;19:205–10.

    Article  PubMed  CAS  Google Scholar 

  4. Casassus P, Fontbonne A, Thibult N, et al. Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris prospective study. Arterioscler Thromb Vasc Biol 1992;12:1387–92.

    CAS  Google Scholar 

  5. Freskens EJM, Kromhout D. Hyperinsulinemia, risk factors and coronary artery disease. Arterioscler Thromb Vasc Biol 1994;14:1641–7.

    Google Scholar 

  6. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952–7.

    Article  PubMed  CAS  Google Scholar 

  7. Randle PJ, Garland PB, Hales CN, Newshholme EA. The glucose fatty acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;Apr 1:785–9.

    Article  Google Scholar 

  8. Nuutila P, Koivisto VA, Knuuti J, Ruotsalainen U, Teras M, Haaparanta M, et al. The glucose free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 1992;89:1767–74.

    Article  PubMed  CAS  Google Scholar 

  9. Barrett E, Schwartz RG, Francis CK, Zaret BL. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog. J Clin Invest 1984;74:1073–9.

    Article  PubMed  CAS  Google Scholar 

  10. Phelps ME, Hoflimn EJ, Selin C, Huang SC, Robinson G, MacDonald N, et al. Investigation of (F-18)2-fluoro-2-deoxyglucose for the measurement of myocardial glucose metabolism. J Nucl Med 1978;19:1311–9.

    PubMed  CAS  Google Scholar 

  11. Gambhir SS, Schwaiger M, Huang SC, Krivakpiitch J, Schelbert HR, Nienaber CA, et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18-deoxyglucose. J Nucl Med 1989;30:359–66.

    PubMed  CAS  Google Scholar 

  12. Ohtake T, Kosaka N, Watanabe T, Yokoyama I, Moritan T, Masuo M, et al. Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs. J Nucl Med 1991;32:1432–8.

    PubMed  CAS  Google Scholar 

  13. Ohtake T, Yokoyama I, Moritan T, Momose T, Oku S, Nishikawa J, et al. Myocardial glucose metabolism in noninsulin dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med 1995;36:456–63.

    PubMed  CAS  Google Scholar 

  14. Raitib O, Phelps ME, Huang SC, Henze E, Selin CE, Schelbert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 1982;23:577–86.

    Google Scholar 

  15. Krivokapich J, Huang S-C, Selin CE, Phelps ME. Fluorine-deoxyglucose rate constants, lumped constant, and glucose metabolic rate in rabbit heart. Am J Physiol 1987;252:H777–87.

    PubMed  CAS  Google Scholar 

  16. Voipio-Pulkki LM, Nuutila P, Knuuti J, et al. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med 1993;34:2064–7.

    PubMed  CAS  Google Scholar 

  17. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Yamada N, Nishikawa J, et al. Organ specific insulin resistance in patients with non-insulin dependent diabetes mellitus and hypertension. J Nucl Med 1998;39:884–9.

    PubMed  CAS  Google Scholar 

  18. Nuutila P, Maeki M, Laine H, Knuuti J, Ruotsalainen U, Kuotohahiti M, et al. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J Clin Invest 1995;96:1003–9.

    Article  PubMed  CAS  Google Scholar 

  19. Nuutila P, Kunuuti J, Maki M, Laine H, Luotsalainen U, Teras M, et al. Gender and insulin sensitivity in the heart and skeletal muscles. Studies using positron emission tomography. Diabetes 1995;44:31–6.

    Article  PubMed  CAS  Google Scholar 

  20. Maki M, Nuutila P, Laine H, Voipio-Pulkki LM, Haparanta M, Solin O, Kunuuti J. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease. Diabetes 1997;46:1491–6.

    Article  PubMed  CAS  Google Scholar 

  21. Ng CK, Holden JE, Degrado TR, Raffel DM, Komguth ML, Gatley SJ. Sensitivity of myocardial fluorodeoxyglucose lumped constant to glucose and insulin. Am J Physiol 1991;260:H593–603.

    PubMed  CAS  Google Scholar 

  22. Ng CK, Soufer R, McNulty PH. Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake. J Nucl Med 1998;39:379–83.

    PubMed  CAS  Google Scholar 

  23. Bøtker HE, Bottcher M, Schmitz O, Gee A, Hansen SB, Cold GE, et al. Glucose uptake and lumped constant variability in normal human hearts determined with [18F] fluorodeoxyglucose. J Nucl Cardiol 1997;4:125–32.

    Article  PubMed  Google Scholar 

  24. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Kobayakawa N, Aoyagi T, et al. Insulin action on heart and skeletal muscle FDG uptake in patients with hypertriglyceridemia. J Nucl Med 1999;40:1116–21.

    PubMed  CAS  Google Scholar 

  25. Ehrenkaufer RE, Potocki JF, Jewett DM. Simple synthesis of F-18 labeled 2-fluoro-2-deoxy-D-glucose. J Nucl Med 1989;25:333–7.

    Google Scholar 

  26. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Nishikawa J, Sasaki Y, et al. Hyperglycemia but not insulin resistance is related to coronary flow reserve in patients with non-insulin dependent diabetes mellitus. Diabetes 1998;47:119–24.

    Article  PubMed  CAS  Google Scholar 

  27. Hicks RJ, Herman WH, Kalff V, Molina E, Wolfe ER, Hutchins G, et al. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography. J Am Coll Cardiol 1991;18:101–10.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ikuo Yokoyama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yokoyama, I., Yonekura, K., Ohtake, T. et al. Role of insulin resistance in heart and skeletal muscle F-18 fluorodeoxyglucose uptake in patients with noninsulin-dependent diabetes mellitus. J Nucl Cardiol 7, 242–248 (2000). https://doi.org/10.1016/S1071-3581(00)70013-4

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1071-3581(00)70013-4

Key Words

Navigation